EcoDrugPlus

Atp-Binding Cassette, Sub-Family B (Mdr/tap), Member 1a

Ensembl ID : ENSMAUG00000012772
Gene Symbol: ABCB1A
1 Cross references
148 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSMAUG00000012880
Gene Symbol: ATP4B
4 Cross references
184 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSMAUG00000017136
Gene Symbol: ATP1A1
3 Cross references
322 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSMAUG00000017529
Gene Symbol: ATP1B1
4 Cross references
294 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSMAUG00000021762
Gene Symbol: ATP1B2
4 Cross references
274 Possible Orthologues:

Atpase, H+/k+ Exchanging, Gastric, Alpha Polypeptide

Ensembl ID : ENSMAUG00000020584
Gene Symbol: ATP4A
1 Cross references
183 Possible Orthologues:

Atpase, Na+/k+ Transporting, Alpha 2 Polypeptide

Ensembl ID : ENSMAUG00000009483
Gene Symbol: ATP1A2
1 Cross references
205 Possible Orthologues:

Atpase, Na+/k+ Transporting, Alpha 4 Polypeptide

Ensembl ID : ENSMAUG00000013532
Gene Symbol: ATP1A4
1 Cross references
564 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSMAUG00000016915
Gene Symbol: AXL
2 Cross references
197 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSMAUG00000010979
Gene Symbol: BCL2
3 Cross references
227 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSMAUG00000004031
Gene Symbol: BCL2L1
4 Cross references
287 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSMAUG00000007608
Gene Symbol: BCL2L10
3 Cross references
129 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).